The SPECTRA Study

PHASE2TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

March 31, 2003

Study Completion Date

June 30, 2003

Conditions
Rheumatoid Arthritis
Interventions
DRUG

anakinra

anakinra

DRUG

anakinra and PEG sTNF-R1

anakinra and PEG sTNF-R1

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00537667 - The SPECTRA Study | Biotech Hunter | Biotech Hunter